Bicara Therapeutics Inc. Common Stock
USD29.21
-0.13 (-0.44%)
CEO
Claire Mazumdar Clemon
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.51
Prev. Close
$29.34
Day Low
$28.99
Day High
$29.82
52W Low
$8.74
52W High
$29.82
Market Cap
$1.60B
Volume
0.81M
| 19,475 |
| $20.56 |
| 10 Jun 2026 | Haviland Kate | director | A-Award | Acquired | 19,475 | $20.56 |
| 10 Jun 2026 | Mazumdar-Shaw Kiran | director | A-Award | Acquired | 19,475 | $20.56 |
| 10 Jun 2026 | Robertson Scott M. | director | A-Award | Acquired | 19,475 | $20.56 |
| 10 Jun 2026 | POWELL MICHAEL | director | A-Award | Acquired | 19,475 | $20.56 |
| 10 Jun 2026 | Simson Jake | director | A-Award | Acquired | 19,475 | $20.56 |
| 26 May 2026 | Hyep Ivan | Chief Financial Officer | M-Exempt | Acquired | 9,200 | $3.79 |
| 26 May 2026 | Hyep Ivan | Chief Financial Officer | S-Sale | Disposed | 9,200 | $20.42 |
| 26 May 2026 | Hyep Ivan | Chief Financial Officer | M-Exempt | Disposed | 9,200 | $3.79 |